| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |